We measured regional cerebral blood flow and [ ]iodoamphetamine (IMP) uptake, in regional cerebral blood flow (rCBF), and in regional cerebral metabolic rate for oxygen (rCMROi), corresponding to the infarct core and hypodensity on the x-ray computed tomogram (CT scan). The peripheral or peri-infarct area was characterized by slight decreases in IMP uptake, rCBF, and rCMRO 2 , with a normal image on the x-ray CT scan that we attributed to diaschisis or selective neuronal loss and not to a chronic ischemic penumbra.
I n a previous study of the pathophysiology of chronic cerebral infarcts, we differentiated the central and peripheral areas. 1 The central area was characterized by a marked decrease in [ l23 I]iodoamphetamine (IMP) uptake, in regional cerebral blood flow (rCBF), and in regional cerebral metabolic rate for oxygen (rCMROi), corresponding to the infarct core and hypodensity on the x-ray computed tomogram (CT scan). The peripheral or peri-infarct area was characterized by slight decreases in IMP uptake, rCBF, and rCMRO 2 , with a normal image on the x-ray CT scan that we attributed to diaschisis or selective neuronal loss and not to a chronic ischemic penumbra.
We studied the central and peripheral areas during the subacute period using single-photon emission computed tomography (SPECT) once, twice, or more times, providing a longitudinal evaluation of both areas. A few patients were also studied using positron emission tomography (PET), providing information on rCMRO 2 in the same areas. The Each patient had a SPECT study with xenon-133 and one with IMP using a Tomomatic 64 providing three slices with 17 mm resolution and later using a Tomomatic 564 providing five contiguous slices with 12 mm resolution. 23 rCBF was measured in each patient as described elsewhere, 4 -6 and results were expressed in milliliters per minute per 100 grams of brain or relative to the contralateral symmetrical value. rCBF was also measured 30 minutes after intravenous injection of 1 g acetazolamide. The normal rCBF increase induced by the drug (acetazolamide reactivity) was found to be approximately 30% 7 ; mean±SD acetazolamide reactivity was 38±19% in the assumed normal hemisphere of 49 patients in our center.
IMP images were routinely obtained 10-30 minutes (IMP 10') and then 5 (IMP 5H) and 24 (IMP 24H) hours after injection. IMP was prepared from a commercial kit (Oris, CEN-Saclay, France) with iodine-123 that was produced by a tellurium-124 (p,2n) iodine-123 reaction and contained <4% iodine-124. Doses injected were 185-259 MBq (5-7 mCi) in 10 mg IMP. IMP uptake results were not corrected for isotope decay and are expressed relative to the contralateral symmetrical value.
Three patients had a PET study of rCBF, rCMRO 2 , and regional oxygen extraction fraction X-ray CT before and after contrast medium administration was carried out in each patient either immediately before or after the radionuclide study.
To facilitate the comparison of SPECT, PET, and CT images, the patient's head was placed in the same position and ink points marking the orbitomeatal line were used as a reference until the end of the study period. The SPECT and PET results expressed relative to the contralateral symmetrical value were calculated as 100 x (contralateral rCBFinfarct rCBFHcontralateral rCBF. The normal ranges of IMP uptake and rCBF had been defined earlier as contralateral values ±6% and 10%, respectively.
1 A change to above or below this normal range was considered to be abnormal. For SPECT and PET, rCBF results were also expressed in absolute amounts. For every patient the central and peripheral areas were delineated on the chronic images using the CT and IMP 5H images for the former and the IMP 10' and IMP 5H images for the latter as described earlier. ' A region of interest (ROI) of 2-5 cm 2 was drawn in these two areas. The ROI limits stored in the computer were transferred to the corresponding rCBF and IMP images of the subacute period.
Every patient was studied during the subacute period (Day 3 to Day 50) and then again after 3 months (chronic period). Studies were repeated on some patients two, three, or four times. Six women and 10 men aged 55-77 years with a unilateral infarct in the middle cerebral artery (MCA) territory were studied. Patients with previous ipsilateral or contralateral ischemic accident or with complete loss of consciousness during the acute period were excluded.
All patients had a cervical Doppler ultrasonogram with echotomography, a four-vessel arteriogram or digital subtraction arterial angiogram (except for Patient 15), a careful cardiac examination with echotomography and electrocardiography (ECG), and biochemical tests to evaluate the degree and extent of atheromatous and hypertensive disease and the role of coagulation and platelet dysfunction.
Of the 13 right-handed patients, six had right hemiplegia and aphasia associated with right hemisensory deficit and/or hemianopsia, one had severe Wernicke's aphasia and right hemianopsia, and the other six had left hemiplegia and right hemisphere cortical dysfunction (left hemivisual field and hemibody neglect, anosognosia, spatial agnosoapraxia) associated with hemisensory deficit and in some patients with hemianopsia ( Table 1) . The three ambidextrous patients had right hemiplegia and aphasia associated with signs of right hemispheric cortical dysfunction and hemisensory deficit (or hemianopsia in one). Twelve of the 16 patients were able to return home during the chronic period, one died of myocardial infarction (Patient 10), and three were institutionalized temporarily (Patients 4 and 8) or indefinitely (Patient 15).
The infarct was mainly superficial in five patients, mainly deep in one, and both deep and superficial in 10 (Table 1) . Cerebral angiography showed atheromatous occlusion or tight stenosis (of at least 80%) of the homolateral internal carotid artery (ICA) in 11 patients and atheromatous plaques with mild stenosis in one. An embolic process of ICA origin was suspected in 12 patients (Patients 3-6,8-10, and 12-16) because of a lesion in the center of the ICA territory and marked contrast enhancement or hemorrhagic hyperdensity. A hemodynamic process was found in four patients with watershed image associated with ICA occlusion (Patients 2, 7, and 11) or tight stenosis (Patient 1). In three patients with ICA occlusion, the stroke occurred at the time of the occlusion and followed endarterectomy (Patient 2), Doppler examination (Patient 8), or angiography (Patient 11); in the three patients known to have tight stenosis (Patients 7, 14, and 16), a fresh occlusion was assumed to have occurred on the basis of angiographic and clinical data.
Results
Results obtained in the subacute period are presented separately for the central and peripheral areas; the areas were defined on the chronic period images.
Central Area
In the subacute period the central area's rCBF and IMP uptake fluctuated with time (Figures 1 and  2 Table 2 .
Phase 1 was studied in only two patients, both of whom were seen on Day 3 ( Table 2 ). The central area was characterized by low rCBF, low IMP uptake at 10 minutes and 5 hours, and a hypodense image on CT scan.
Phase 2 was studied in 14 patients (Table 2 ). Mean rCBF was low in Phase 2a (-19%), increased to normal (5%) in Phase 2b with a maximum around Day 15, and then decreased in Phase 2c (-8%) ( Figure 1 ). Acetazolamide reactivity was extremely low, with mean values of 5-11% for Phases 2a, 2b, and 2c (Figures 1 and 3 ). Before administration of the drug the central area could be visually detected in four of 15 patients; after administration the central area was visible in nine of 11 patients. Uptake of IMP at 10 minutes was slightly decreased or normal, with mean values of -9%, -9%, and -10% for Phases 2a, 2b, and 2c, respectively. Uptake of IMP at 5 hours was approximately nor- During Phase 2, the central area was hypodense on the CT scan in nine, spontaneously hyperdense in four, and normal in one of the 14 patients. Contrast enhancement was observed in 11 of the 13 patients who were given an injection of contrast medium. Phase 3 was studied in 11 patients (Table 2 ). Mean rCBF was lower than normal and decreased with time; the mean decreases for Phases 3a and 3b were -10% and -49%, respectively. Acetazolamide reactivity was low with mean values of 6% and 11%. Uptake of IMP at 10 minutes was slightly lower in Phase 3 than in Phase 2, with mean decreases of -12% and -27%, respectively, for Phases 3a and 3b. Uptake of IMP at 5 hours decreased slowly over time from higher-thannormal to lower-than-normal values, with respective mean values of 7% and -8 % ; uptake of IMP at 24 hours, calculated in fewer patients, also decreased with time but remained higher than normal, with mean values of 25% and 8%, respectively, for Phases 3a and 3b. In Phase 3, as in Phase 2, hyperfixation was more clearly observed on 24-hour than on 5-hour IMP images (Figures 4 and 5 ). During Phase 3, the central area was hypodense in nine and spontaneously hyperdense in one. Contrast enhancement was still present in eight and difficult to detect in one of 10 patients injected with contrast medium.
Although values from the chronic period were reported in detail elsewhere, 1 we summarize them here because they may be compared with the subacute values in every patient ( Table 2) . rCBF of the central area was very low, with a mean decrease of 49%, identical to that observed in Phase 3b. Mean acetazolamide reactivity was 22%. Mean IMP uptake at 10 minutes, 5 hours, and 24 hours decreased by 33%, 22%, and 13%, respectively, and was lower than in the subacute period; this suggested that hyperfixation persisted beyond Day 50. In the chronic phase, CT showed a hypodense area in all patients and contrast enhancement in only two. When the central area data of the subacute and chronic periods were plotted against time (Figures 1  and 2 ), the highest values were reached on Day 15 for resting rCBF and IMP uptake at 10 minutes and on Day 19 for rCBF after acetazolamide administration and uptake of IMP at 5 and 24 hours. In both the subacute and chronic periods, mean acetazolamide reactivity and mean uptake of IMP at 24 hours were calculated in fewer patients than were used for rCBF and uptake of IMP at 10 minutes and 5 hours.
In the three patients who had a PET study, rOEF and rCMR0 2 were decreased ( 9 the three patients showed luxury perfusion.
Peripheral Area
rCBF and uptake of IMP at 10 minutes were slightly lower than contralateral values during the entire subacute period for all patients (Table 4) , and mean values decreased by 16% and 11%, respectively ( Figure 6 ). Mean acetazolamide reactivity was 28% in the peripheral area and 37% in the contralateral area. In all patients the values for uptake of IMP at 5 and 24 hours were normal in the subacute period as they were in the chronic period. Despite the slight decrease in rCBF and uptake of IMP at 10 minutes in the peripheral area, neither CT hypodensity nor contrast enhancement was observed in the subacute period. 1 Two of the three patients examined by PET and SPECT had a peripheral area large enough to be studied. Both had a slight but not significant Xe and rCMR0 2 (Table 3) ; rOEF was normal as in chronic infarct. 1 
Contralateral Hemisphere
For every study, two areas were measured in the unaffected hemisphere, one symmetrical to the central area and the other symmetrical to the peripheral area. No significant difference was evident between these two areas. Mean±SD rCBF of these contralateral areas taken together in the subacute period (44.4±8.6 ml/min/100 g) was 13% lower than in the chronic period. To evaluate the significance of this moderate decrease, differences between rCBF during the chronic and subacute periods were calculated separately for each patient. The mean±SD differences were 6.37±2.11 ml/min/100 g and 7.20±1.92 ml/min/100 g; both differences were significant (atp<0.025 and p<0.05, respectively) using the paired / test.
After injection of acetazolamide, mean±SD rCBF of the same contralateral areas in the subacute period (61.7± 11.5 ml/min/100 g) was also 12% lower than in the chronic period. Individual mean differences (8.7± 14.8 and 7.9±9.6 ml/min/100 g) were significant atp<0.01 and p<0.001, respectively, using the paired / test. Before and after acetazolamide, these figures indicated that rCBF in the contralateral hemisphere was significantly lower during the subacute period than during the chronic period.
IMP Kinetics
IMP uptake was measured in three areas in 11 studies 30 minutes, 1,5, and 24 hours after injection between Days 10 and 30 of the subacute period; the areas were a hyperfixation zone of the central area, a peripheral area, and the unaffected hemisphere (normal brain tissue). All values were corrected for radioactive decay.
The IMP curve of normal brain tissue increased for approximately 1 hour and then remained stable ( Figure 7) . The peripheral area curve increased more slowly and joined the normal plateau 2-4 hours later than the normal curve. The hyperfixation curve of the central area increased more quickly, reached normal uptake values at the same time or earlier than the normal curve, but then continuously increased beyond normal values at 5 and 24 hours without showing any plateau.
IMP kinetics of the peripheral and central areas were quite different, with the former showing a plateau similar to that of a normal curve but with a slower initial slope, and the latter showing a continuous increase for as much as 24 hours. •Spontaneously hyperdense image of CT scan. tAcetazolamide reactivity not calculated because resting rCBF was too small. Discussion With our SPECT method, in-plane resolution was 17 mm at the beginning of the study and 14 mm later. This latter value is within the range of the in-plane resolution of many PET systems currently used; the slice thickness (20 mm) is also close to those encountered in several PET systems. Therefore, we do not believe that a partial volume effect can account for the differences we found between regions. The accuracy of the SPECT method has been studied in our laboratory by repeating the measurements after 30 minutes in 37 patients. The within-patient coefficient of variation was 7.5% and was found to be independent of the region. The method was validated in our laboratory by comparing PET and SPECT values obtained in the same cortical ROIs in nine patients with ROIs ranging in size from 3.2 to 6.4 cm 3 . Significant correlation was observed (r=0.78, n=126), and the regression line was rCBF SPECr =0.%xrCBF PET +12.6, showing a systematic overestimation of rCBF PET by SPECT. Although SPECT is not as widely known as PET, it is reliable and just as accurate, at least for cortical areas.
In a recent SPECT study, we showed that two areas can be defined in chronic infarct cases (C. Raynaud, G. Rancurel, E. Kieffer, J.P. Soucy, S. Pappata, J.C. Baron, N.A. Lassen, E. Cabanis, A. Majdalani, A. Bardy, N. Tzourio, S. Ricard, M. Bourguignon, A. Syrota, unpublished data). The central area was characterized by a hypodense region on CT scan, a marked decrease in uptake of IMP at 10 minutes and rCBF, and a smaller decrease in uptake of IMP at 5 hours; the peripheral area, located around the central area, was characterized by a normal CT image, a normal uptake of IMP at 5 hours, and a moderate decrease in rCBF and uptake of IMP at 10 minutes. The results already reported showed that in the central area the decrease was >25%, 20%, and 10% for rCBF and uptake of IMP at 10 minutes and 5 hours, respectively, and that in the peripheral area the decrease was less. We considered these values to be thresholds. The chronic values of the present series agree with the proposed definition and thresholds. However, a few patients had values beyond the described limits; these values might be attributed to a partial volume effect in patients with small infarct (Patient 13) or small peripheral areas, or to a focal increase of rCBF or IMP uptake of the contralateral area; with small variations in contralateral area, the lesion area value can considerably modify the value of the lesion area when expressed as percent difference. To avoid such variations a better reference might be the mean rCBF or IMP uptake of the patient or of the slice.
Hyperfixation was observed on Day 22 and on 24-hour image (IMP24H) (arrow) but not on 5-hour image (IMP5H). Area of hyperfixation corresponded to hypodense area on computed tomogram (CT).
Several authors have reported that in the subacute infarct period the area of decreased blood flow was larger than the CT hypodense zone in he9.io-i5 and SPECT'6 studies. We studied a group of patients in both the subacute and chronic phases. The limits of the ROIs selected in the central and peripheral areas were delineated on the chronic images and transferred to subacute •Value in normal range. images by the computer. Our results indicate that both central and peripheral areas were already present in the subacute period and show pathophysiologic and outcome differences.
The central area was characterized by hyperperfusion and IMP hyperfixation. Hyperperfusion or luxury perfusion has been defined 17 as an overabundant CBF compared with metabolic needs, and it has been described early after stroke (in the first 3 days)is, 18-20 a n ( j [ a t er (during the second and third weeks).
914152 '-23 In this study, we observed only the latter. Late luxury perfusion has been attributed to focal vasodilatation and loss of autoregulation in the reperfused vessels 171923 and new capillaries.
-24
The role of new capillaries has been supported by histologic findings of maximal proliferation contemporaneous with delayed luxury perfusion. 25 Hyperperfusion was detected only when rCBF was greater than contralateral values, that is, in five of our 27 patients. However, when rCBF was retrospectively expressed relative to the central area rCBF in the chronic period, 24 of the 27 subacute studies showed relative hyperperfusion ( Figure 1, bottom) ; this relative hyperperfusion was at its maximum between Days 15 and 20.
IMP hyperfixation was seen more clearly on IMP 24-hour measurements (Figure 2, bottom) . Starting with hyperperfusion at the end of the first week, hyperfixation reached a maximum around Day 20. Although it then decreased slowly, hyperfixation was still present on Day 50; it may be present longer than Day 50, but we do not yet have proof of this. The 24-hour IMP uptake curve differs from the rCBF curve, extending over a longer period; its maximum value appears later than that for hyperperfusion. The most interesting part of the curve is certainly the period from Day 20 to Day 50, when rCBF and uptake of IMP at 24 hours were clearly dissociated, the former being lower than normal and the latter being higher. This dissociation suggests that the two have different origins. IMP hyperfixation may be attributed to a blood-brain barrier disturbance as suggested by the simultaneous presence of IMP hyperfixation at 24 hours and CT contrast enhancement, which we as well as others 25 - 26 have found. IMP kinetics in hyperfixation differed from those observed in normal brain tissue ( Figure 7) . In normal cortex, IMP uptake increased approximately 1 hour after injection and then plateaued as the result of an equilibrium between washin and washout. In hyperfixation, the IMP concentration continued to increase above the normal level recorded in the contralateral area; at 24 hours IMP concentration continued to increase. This increase may be due to either a low or absent washout, reflecting metabolic impairment 27 or to penetration and accumulation through an altered blood-brain barrier of IMP metabolites unable to cross the barrier when normal. This is probably true for hydrophilic IMP metabolites such as p- iodobenzoic acid present in the blood at that time. 27 We also found that hyperfixation coincided with the peak proliferation of fatty macrophages in the necrotic area; such proliferation increased for 3 weeks and then gradually decreased over many months. 24 During the subacute period, delineation of the central area on rCBF and IMP images may be difficult over short periods of time, as shown in Figures 1, bottom and 2 , middle. However, the central area contours may be found on rCBF images obtained after administration of acetazolamide and on images of IMP uptake at 5 and 24 hours. At the same time, the fogging effect masks the hypodense area of the CT scan. 25 The peripheral area in the subacute period was characterized by a moderate decrease in rCBF, acetazolamide reactivity, and uptake of IMP at 10 minutes, associated with a normal-density CT image, just as during the chronic period. 1 In our work including PET studies, this area was characterized by a slight decrease in rCBF and rCMR0 2 , a normal rOEF, and a normal CT image.
-
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- 30 The peripheral area has sometimes been confused with the ischemic penumbra. 31 - 32 The resting rCBF of the peripheral area was normal in one third of our patients (Table 4) ; this surprising result may be due to scattered radiation from the adjacent central area of hyperperfusion. The delineation of the peripheral area was easier on rCBF images obtained after administration of acetazolamide and IMP. The contours of this area corresponded in some patients to the MCA territory and in a few others included the anterior cerebral artery territory unaffected by the ischemia.
It is unlikely that the functional decrease in the peripheral area is responsible for sensory or motor deficit; the size and degree of modification observed in this area remain unchanged for a long period; even so, the neurologic deficits of patients may regress. Peripheral area IMP kinetics was approximately similar to that of normal brain tissue but with a slower build-up since normal values were reached 1 or 2 hours later (Figure 7) . The delayed plateau may be related to slow washin because of decreased rCBF and reduced washout because of decreased metabolism. 27 Selective neuronal loss and diaschisis have been suggested as pathophysiologic mechanisms. 1 Early appearance of the peripheral area and its approximately normal IMP kinetics may favor the diaschisis hypothesis. 33 Evolution is another characteristic of the peripheral area since functional impairment observed without detectable morphologic support remained stable for years.
The decrease in rCBF in the contralateral hemisphere during the subacute period (12% and 13%) relative to that of the chronic phase was significant in our patients before and after administration of acetazolamide. Published results for contralateral rCBF in the subacute period are contradictory. In humans, contralateral rCBF either decreased 91 '-34 - 35 or was normal 13 ; a contralateral rCMR0 2 decrease has also been reported. 13 - 35 In our study the significance of a 13% decrease in rCBF observed before acetazolamide is difficult to determine because Pco 2 was not measured; however, the same decrease found 30 minutes later, after injection of acetazolamide, indicates that variations in PCO2 are unlikely to be the cause. Because each patient was his own control, we did not refer to a normal population value used by most authors. Subacute decrease in the contralateral rCBF was temporary; it was present during the first weeks after a stroke but disappeared after 90 days. In squirrel monkeys, Garcia and Kamijio 36 found reversible cellular changes contralateral to experimental infarcts during the first days but not after the 16th day. In humans this phenomenon has been attributed to dysfunction of the interhemispheric neuronal connection via the corpus callosum 37 ; this phenomenon is referred to as transhemispheric diaschisis 13 -33 - 38 by others. It has also been attributed to a vasomotor response to stimuli from neurochemical ascendant pathways originating in brainstem nuclei. 33 
Conclusion
Our results indicate that two areas, the central area representing the infarct core and the peripheral area developed in the peri-infarct zone, may be differentiated during the subacute period of stroke. Pathophysiology and outcome are different in these two areas, and studies of subacute infarction should consequently refer to the area involved. The central area is the site of wide variations of rCBF and IMP uptake during the development of necrosis. The peripheral area, with its slight decrease in rCBF and IMP uptake without morphologic changes, appears stable because it is present early after the stroke and may persist for years. Knowledge of the spontaneous changes in rCBF and IMP uptake in these two areas during the subacute period will facilitate the evaluation of new treatment for cerebral infarction.
Such longitudinal studies, essential in reducing variations observed in a population that is inevitably heterogeneous, should be encouraged. The SPECT method of measuring rCBF is well adapted to sequential studies because it is noninvasive and requires only a few minutes. It provides pathophysiologic data that can be studied only with difficulty using PET.
